Official account of The University of Texas MD Anderson Cancer Center. Our mission is to #EndCancer through patient care, research, education & prevention.
ALT UT MD Anderson is #1 in the nation for cancer care, with white text. Below are the UT MD Anderson Cancer logo and a gold USNews Best Hospitals Cancer 2026-2027 badge, on a red-purple gradient background.
A new UT MD Anderson study identified two factors that may determine how well off-the-shelf CAR T cells expand and persist in patients: immune rejection by the patient and the “fitness” of the donor-derived CAR T cells.
The findings could help improve future CAR T cell therapies: spr.ly/6014BGcIRM#EndCancer@pbachi
An AI model developed at UT MD Anderson can predict which lung cancer patients may be at higher risk of pneumonitis, a potentially life-threatening side effect of immunotherapy.
Learn more: spr.ly/6012BGcIrr#EndCancer@JiaWu_PhD@ajaysheshadri
Anal cancer is rare, but diagnoses are increasing in the U.S.
On the latest Cancerwise podcast, Drs. Emma Holliday and Van Morris discuss anal cancer causes, prevention, treatment advances and ways to protect quality of life.
Listen now: spr.ly/6016BGcUHp@DrEmmaHolliday@VanMorrisMD#EndCancer
Our Dr. Clifton Fuller has been recognized by @ASTRO_org with the 2026 Mentorship Award, which honors mentors in radiation oncology who demonstrate outstanding commitment to the professional development of clinicians, educators and researchers. #ASTRO26#EndCancer
ALT Graphic reads, \"Congratulations 2026 ASTRO Mentorship Award. Clifton David Fuller, M.D., Ph.D.\"
Get to know UT MD Anderson's Chief Scientific Officer, Dr. Albert Koong.
He shares what led him to UT MD Anderson, about his lab's investigations into the tumor microenvironment and what excites him about the future of research: spr.ly/6001BG9U7l@ACKoongMDPhD#EndCancer
Congratulations to our Dr. Chelsea Pinnix on being named a 2026 @ASTRO_org fellow! She is recognized for her contributions to the field of radiation oncology.
Learn more about UT MD Anderson's presence at #ASTRO26: spr.ly/6018BGguXi#EndCancer
ALT Graphic reads, \"Congratulations to our 2026 Fellow of the American Society for Radiation Oncology. Chelsea Pinnix, M.D., Ph.D.\"
Researchers have identified a pathway that prostate tumors leverage to suppress the immune system by reshaping the tumor microenvironment.
How a targeted therapy approach prolonged survival in preclinical models: spr.ly/6015BGdaz5@Dr_Di_Zhao@nicholas_navin#EndCancer
Neuropathy is a common side effect of some cancer treatments.
Dr. Moran Amit explains what neuropathy is, how it can affect patients and why researchers are focusing on preventing it rather than treating it after it develops: spr.ly/6016BGdr3m@moranamit2#EndCancer
It’s likely that more than 1 million patients have benefited from immunotherapy since 2011.
But immunotherapy is not yet curing every patient. The James P. Allison Institute™ is committed to bringing the benefits to all patients: spr.ly/6013BGbWR7#EndCancer
The most important thing to do after receiving an abnormal Pap test is to seek follow-up care, says our Dr. Kathleen Schmeler.
Learn more: spr.ly/6010BGp0Wu@kmschmeler#EndCancer
Researchers have identified a role for B cells in triggering colitis occurring as a side effect of immune checkpoint inhibitors.
The findings provide a potential biomarker to identify patients at risk of immunotherapy-related colitis: spr.ly/6010BGn2a2#EndCancer
Research is investigating how coffee affects not only the risk of prostate cancer, but also whether it can prevent recurrence or progression.
Dr. @JustinRGregg shares what his team found regarding coffee on prostate cancer: spr.ly/6013BGna3L@EverydayHealth#EndCancer
Together with @UTexasResearch, UT MD Anderson is collaborating on TRIUMPH-IBC, an interdisciplinary and multi-institutional research project.
How the group aims to improve outcomes for patients with inflammatory breast cancer: spr.ly/6011BGr8dS@IBCradiation#EndCancer
Thyroid nodules are very common, especially as people age.
Dr. Steven Weitzman shares more and what makes UT MD Anderson’s Thyroid Nodule Clinic unique: spr.ly/6014BGTPSa@DrSWeitzman1#EndCancer
UT MD Anderson and @SpringerNature will co-host "Next Generation Cancer Therapeutics," a conference on the latest research and advances in the development of treatment modalities and the technologies enabling them.
Learn more and register: spr.ly/6017BGRCvW#EndCancer
Findings from a Phase 1/2 trial found that targeting the gut microbiome with fecal microbiota transplantation may help cancer patients with immunotherapy-related colitis avoid the need for immune-suppressing treatments: spr.ly/6013BGR405#EndCancer
Devices that measure activity are effective at encouraging you and monitoring your progress as you work to improve your health.
Dr. Karen Basen-Engquist breaks down their accuracy and what they can tell you about your health: spr.ly/6015BGu96b@K_BasenEngquist#EndCancer
The countdown is on to UT MD Anderson’s Boot Walk to End Cancer®.
Our kickoff in Sugar Land brought the community together to shine boots, create keepsakes, honor loved ones and build momentum for Nov. 14.
We’ll see you there as we come together to #EndCancer.
The glycemic index is a tool that can help you make healthier food choices.
Dr. Nurpur Kikani shares what index scores mean and how people with diabetes can use it to keep their blood sugars in check: spr.ly/6017BGHb3W#EndCancer